CoreLine Soft Co

CoreLine Soft Co EBITDA Margin

The EBITDA Margin of CoreLine Soft Co (384470.KQ) as of Oct 16, 2026 is -338.08 %. In the previous year, EBITDA Margin was -265.41 % — a change of 27.38% (lower).

EBITDA Margin

-338.08 %

YoY

27.38%

Last updated:

EBITDA Margin of CoreLine Soft Co is 2024 -338.08 % . EBITDA Margin of CoreLine Soft Co was 2023 -265.41 % . It decreases by 27.38% lower compared to the previous year.

The CoreLine Soft Co EBITDA Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA Margin
Date
EBITDA Margin
Jan 1, 2020
-137.20 KRW
Jan 1, 2021
-320.90 KRW
Jan 1, 2022
-229.87 KRW
Jan 1, 2023
-265.41 KRW
Jan 1, 2024
-338.08 KRW
The CoreLine Soft Co EBITDA Margin history
YEAREBITDA MarginYoY
-338.08 %+27.38%
-265.41 %+15.46%
-229.87 %-28.37%
-320.90 %+133.90%
-137.20 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

CoreLine Soft Co Stock analysis

What does CoreLine Soft Co do? CoreLine Soft Co Ltd is a South Korean company headquartered in Seoul, operating within the Health Care sector. The company went public on September 18, 2023, with its stock listed under the ticker 384470.KQ and ISIN KR7384470001. CoreLine Soft focuses on the development and supply of medical software, specifically artificial intelligence-based solutions for medical image analysis. Its primary products involve software that assists medical professionals in diagnosis and supports treatment and research through the analysis of computed tomography (CT) images of the chest, head, and neck. The company operates in the Health Care Technology industry, providing technology-driven tools to enhance medical imaging processes. CoreLine Soft's services aim to improve efficiency and accuracy in medical diagnostics by leveraging AI technology. The company's website is https://www.corelinesoft.com, offering further information about its solutions and services. As a newly listed company, CoreLine Soft is positioned within the growing field of health care technology, contributing to advancements in medical imaging analysis through its specialized software offerings. CoreLine Soft Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about CoreLine Soft Co stock

EBITDA Margin of CoreLine Soft Co is -338.08 % in 2024.

EBITDA Margin of CoreLine Soft Co changed from -265.41 % to -338.08 %, representing a 27.38% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA Margin CoreLine Soft Co since 2006 – with annual values, charts, and detailed analysis.

EBITDA Margin shows what percentage of revenue converts to EBITDA. It normalizes for depreciation and capital structure differences.

A 'good' varies by industry and company stage. On Eulerpool, you can compare EBITDA Margin's CoreLine Soft Co with sector peers and the industry average to assess whether it is attractive.

To evaluate EBITDA Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EBITDA Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — CoreLine Soft Co

All Key Metrics — CoreLine Soft Co